Skip to main content

Table 3 Changes of COPD assessment test (CAT) score after therapy (N = 52)

From: Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

Clinical variable BOS diagnosis 3 months treatment P-value
Q1. Cough 1.5 (0–2) 1 (0–2) .022
Q2. Phlegm 1 (0–2) 1 (0–2) .983
Q3. Chest tightness 2 (1–3) 1 (0–2) .000
Q4. Breathlessness going up hills/stairs 3 (2–4) 3 (1.25-3) .002
Q5. Activity limitation at home 1 (0–2) 0 (0–1) .054
Q6. Confidence leaving home 1 (0–3) 1 (0–2) .013
Q7. Sleep 2 (1–3) 1 (0–2.75) .004
Q8. Energy 2 (2–3) 2 (1–3) .035
Total sum of the eight items 15.5 (9.25–19.0) 11.0 (6.0–15.75) .001
  1. Data represent the median (IQR). P-values shown in bold are significant at the 0.05 level